Found: 23
Select item for more details and to access through your institution.
Advances in the treatment of type 2 diabetes: impact of dulaglutide.
- Published in:
- Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2016, v. 9, p. 125, doi. 10.2147/DMSO.S75452
- By:
- Publication type:
- Article
Low incidence of gastrointestinal adverse events over time with a fixed‐ratio combination of insulin glargine and lixisenatide versus lixisenatide alone.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 11, p. 2690, doi. 10.1111/dom.13444
- By:
- Publication type:
- Article
Intranasal Glucagon: A New Way to Treat Hypoglycemic Emergencies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Semaglutide: The Newest Once-Weekly GLP-1 RA for Type 2 Diabetes.
- Published in:
- 2018
- By:
- Publication type:
- journal article
iGlarLixi: A Fixed-Ratio Combination of Insulin Glargine 100 U/mL and Lixisenatide for the Treatment of Type 2 Diabetes.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Comparison of New Pharmacological Agents for the Treatment of Obesity.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Comparison of the Usability, Accuracy, Preference, and Satisfaction of Three Once-Weekly Glucagon-Like Peptide 1 Receptor Agonist Pen Devices in People With Type 2 Diabetes.
- Published in:
- Diabetes Spectrum, 2023, v. 36, n. 1, p. 5, doi. 10.2337/ds21-0108
- By:
- Publication type:
- Article
Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen Devices.
- Published in:
- Diabetes Spectrum, 2018, v. 31, n. 4, p. 359, doi. 10.2337/ds17-0048
- By:
- Publication type:
- Article
Basal Insulin Use With GLP-1 Receptor Agonists.
- Published in:
- Diabetes Spectrum, 2016, v. 29, n. 3, p. 152, doi. 10.2337/diaspect.29.3.152
- By:
- Publication type:
- Article
Erratum: Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages. Clinical Diabetes 2023;41:467–473.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Special Report: Potential Strategies for Addressing GLP-1 and Dual GLP-1/GIP Receptor Agonist Shortages.
- Published in:
- Clinical Diabetes, 2023, v. 41, n. 3, p. 467, doi. 10.2337/cd23-0023
- By:
- Publication type:
- Article
Lixisenatide, a Once-Daily Prandial Glucagon-Like Peptide-1 Receptor Agonist for the Treatment of Adults with Type 2 Diabetes.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 8, p. 927, doi. 10.1002/phar.1962
- By:
- Publication type:
- Article
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 Diabetes.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 4, p. 481, doi. 10.1002/phar.1903
- By:
- Publication type:
- Article
Liraglutide: A New Option for the Treatment of Obesity.
- Published in:
- Pharmacotherapy, 2015, v. 35, n. 10, p. 926, doi. 10.1002/phar.1639
- By:
- Publication type:
- Article
GLP-1 Receptor Agonists for Type 2 Diabetes Mellitus: Recent Developments and Emerging Agents.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 11, p. 1174, doi. 10.1002/phar.1507
- By:
- Publication type:
- Article
Interprofessional Education: Principles and Application A Framework for Clinical Pharmacy.
- Published in:
- Pharmacotherapy, 2009, v. 29, n. 7, p. 879, doi. 10.1592/phco.29.7.879
- By:
- Publication type:
- Article
Effects of Pioglitazone or Exercise in Older Adults with Mild Cognitive Impairment and Insulin Resistance: A Pilot Study.
- Published in:
- Dementia & Geriatric Cognitive Disorders Extra, 2015, v. 5, n. 1, p. 51, doi. 10.1159/000371509
- By:
- Publication type:
- Article
Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 12, p. 1979, doi. 10.1007/s13300-023-01464-8
- By:
- Publication type:
- Article
Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump Therapy.
- Published in:
- Diabetes Therapy, 2019, v. 10, n. 4, p. 1337, doi. 10.1007/s13300-019-0634-2
- By:
- Publication type:
- Article
Dulaglutide: The Newest GLP-1 Receptor Agonist for the Management of Type 2 Diabetes.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 3, p. 351, doi. 10.1177/1060028014564180
- By:
- Publication type:
- Article
Technosphere Insulin (Afrezza): A New, Inhaled Prandial Insulin.
- Published in:
- Annals of Pharmacotherapy, 2015, v. 49, n. 1, p. 99, doi. 10.1177/1060028014554648
- By:
- Publication type:
- Article
Albiglutide: a new GLP-1 receptor agonist for the treatment of type 2 diabetes.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Albiglutide: A New GLP-I Receptor Agonist for the Treatment of Type 2 Diabetes.
- Published in:
- Annals of Pharmacotherapy, 2014, v. 48, n. 11, p. 1494, doi. 10.1177/1060028014545807
- By:
- Publication type:
- Article